CE Anthony Schembri, Nadia Levin, Professor Bruce Robinson, Associate Professor Naomi Hammond and Dr Kim Sutherland NSLHD Research Strategy cements northern Sydney’s position as innovation leader Northern Sydney Local Health District has launched its Research Strategy to 2030, an exciting roadmap to advance research and clinical trials across the district. The strategy reflects a shared vision to lead research and clinical trials today for healthier lives tomorrow, and reinforces the central role research plays in delivering world-class healthcare. NSLHD Chief Executive Anthony Schembri launched the strategic framework saying research is fundamental to how we improve care. “By embedding research into everyday clinical practice, translating new knowledge, and strengthening the systems that enable innovation, we will continue to build a new learning health system that evolves with the needs of our patients,” he said. The strategy sets out four priority areas for action; embedding research as a core part of care, translating knowledge, enabling research through strong governance, infrastructure, and workforce support, and partnering to expand collaboration and co-design. The priorities will help grow capability and deliver meaningful improvements in health outcomes for our community. The launch of the research strategy coincided with International Clinical Trials Day, an opportunity to recognise the vital role clinical trials play in advancing healthcare. “Clinical trials are central to delivering innovation in care, providing patients with access to new therapies, and strengthening our reputation as a leading research-intensive health service,” said Anthony. “I would like to thank everyone involved in delivering research and clinical trials across the district. It is encouraging to see continued growth in this area, including the opening of our new Phase I Clinical Trials Unit and the establishment of a second dedicated clinical trials space.” Executive Director of Research Associate Professor Naomi Hammond said the investments reflect our commitment to expanding clinical trial capacity and capability. “It is also a call to action for all of us,” she said. “Research is not the responsibility of a few – it is an opportunity for every member of our workforce to contribute to improving care.” The strategy can be viewed here: https://online.flippingbook.com/view/740455194/
WWW.NSLHD.HEALTH.NSW.GOV.AU
3
Made with FlippingBook - professional solution for displaying marketing and sales documents online